By Cristy Lytal

Three newly assembled research teams within USC Stem Cell, the regenerative medicine initiative at USC, will take steps that could lead to future stem-cell based therapies for certain forms of deafness, bone defects and pediatric leukemia.

The teams are the winners of USC’s Regenerative Medicine Initiative (RMI), a University-wide program kick-started by $1.2 million in funding from the office of Carmen A. Puliafito, MD, MBA, dean of the Keck School of Medicine of USC. Each RMI Award provides up to $200,000 per year for two years to multi-investigator research collaborations that harness the full potential of USC-affiliated faculty members. … Read More »